Incidence and Outcome of Surgical Procedures After Coronary Bare-Metal and Drug-Eluting Stent Implantation A Report From the CREDO-Kyoto PCI/CABG Registry Cohort-2

被引:39
作者
Tokushige, Akihiro
Shiomi, Hiroki
Morimoto, Takeshi [2 ,3 ]
Furukawa, Yutaka [4 ]
Nakagawa, Yoshihisa [5 ]
Kadota, Kazushige [6 ]
Iwabuchi, Masashi [7 ]
Shizuta, Satoshi
Tada, Tomohisa
Tazaki, Junichi
Kato, Yoshihiro
Hayano, Mamoru
Abe, Mitsuru [8 ]
Ehara, Natsuhiko [4 ]
Inada, Tsukasa [9 ]
Kaburagi, Satoshi [10 ]
Hamasaki, Shuichi [11 ]
Tei, Chuwa [11 ]
Nakashima, Hitoshi [12 ]
Ogawa, Hisao [13 ]
Tatami, Ryozo [14 ]
Suwa, Satoru
Takizawa, Akinori
Nohara, Ryuji [15 ]
Fujiwara, Hisayoshi [16 ]
Mitsudo, Kazuaki [6 ]
Nobuyoshi, Masakiyo [7 ]
Kita, Toru
Kimura, Takeshi [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Med, Clin Epidemiol Unit, Kyoto 6068507, Japan
[4] Gen Hosp, Kobe City Med Ctr, Dept Cardiovasc Med, Kobe, Hyogo, Japan
[5] Tenri Hosp, Div Cardiol, Tenri, Nara, Japan
[6] Kurashiki Cent Hosp, Div Cardiol, Kurashiki, Okayama, Japan
[7] Kokura Mem Hosp, Div Cardiol, Fuzhou, Peoples R China
[8] Kyoto Med Ctr, Div Cardiol, Kyoto, Japan
[9] Osaka Red Cross Hosp, Div Cardiol, Osaka, Japan
[10] Shizuoka Prefectural Gen Hosp, Div Cardiol, Shizuoka, Japan
[11] Kagoshima Univ, Grad Sch Med, Dept Cardiovasc Resp & Metab Med, Kagoshima 890, Japan
[12] Natl Hosp Org, Kagoshima Med Ctr, Div Cardiol, Kagoshima, Japan
[13] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 860, Japan
[14] Maizuru Kyosai Hosp, Div Cardiol, Kyoto, Japan
[15] Kitano Hosp, Div Cardiol, Osaka, Japan
[16] Hyogo Kenritsu Amagasaki Hosp, Div Cardiol, Hyogo, Japan
关键词
stents; surgery; thrombosis; bleeding; coronary artery disease; NONCARDIAC SURGERY; ANTIPLATELET THERAPY; DISCONTINUATION; THROMBOSIS;
D O I
10.1161/CIRCINTERVENTIONS.111.963728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-There still remain safety concerns on surgical procedures after coronary drug-eluting stents (DES) implantation, and optimal management of perioperative antiplatelet therapy (APT) has not been yet established. Methods and Results-During 3-year follow-up of 12 207 patients (DES=6802 patients and bare-metal stent [BMS] only=5405 patients) who underwent coronary stent implantation in the CREDO-Kyoto registry cohort-2, surgical procedures were performed in 2398 patients (DES=1295 patients and BMS=1103 patients). Surgical procedures (early surgery in particular) were more frequently performed in the BMS group than in the DES group (4.4% versus 1.9% at 42-day and 23% versus 21% at 3-year, log-rank P=0.0007). Cumulative incidences of death/myocardial infarction (MI)/stent thrombosis (ST) and bleeding at 30 days after surgery were low, without differences between BMS and DES (3.5% versus 2.9%, P=0.4 and 3.2% versus 2.1%, P=0.2, respectively). The adjusted risks of DES use relative to BMS use for death/MI/ST and bleeding were not significant (hazard ratio: 1.63, 95% confidence interval: 0.93 to 2.87, P=0.09 and hazard ratio: 0.6, 95% confidence interval: 0.34 to 1.06, P=0.08, respectively). The risks of perioperative single- and no-APT relative to dual-APT for both death/MI/ST and bleeding were not significant; single-APT as compared with dual-APT tended to be associated with lower risk for death/MI/ST (hazard ratio: 0.4, 95% confidence interval: 0.13 to 1.01, P=0.053). Conclusions-Surgical procedures were commonly performed after coronary stent implantation, and the risk of ischemic and bleeding complications in surgical procedures was low. In patients selected to receive DES or BMS, there were no differences in outcomes. Perioperative administration of dual-APT was not associated with lower risk for ischemic events. (Circ Cardiovasc Interv. 2012;5:237-246.)
引用
收藏
页码:237 / 246
页数:10
相关论文
共 16 条
[1]  
Alshawabkeh LI, 2011, HELL J CARDIOL, V52, P141
[2]   Characterization of Post-Operative Risk Associated With Prior Drug-Eluting Stent Use [J].
Anwaruddin, Saif ;
Askari, Arman T. ;
Saudye, Hammad ;
Batizy, Lilian ;
Houghtaling, Penny L. ;
Alamoudi, Mohammad ;
Militello, Michael ;
Muhammad, Kamran ;
Kapadia, Samir ;
Ellis, Stephen G. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (06) :542-549
[3]   Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: A retrospective cohort study [J].
Brotman, Daniel J. ;
Bakhru, Mihir ;
Saber, Wael ;
Aneia, Ashish ;
Bhatt, Deepak L. ;
Tillan-Martinez, Katherina ;
Jaffer, Amir K. .
JOURNAL OF HOSPITAL MEDICINE, 2007, 2 (06) :378-384
[4]   Previous Coronary Stent Implantation and Cardiac Events in Patients Undergoing Noncardiac Surgery [J].
Cruden, Nicholas L. M. ;
Harding, Scott A. ;
Flapan, Andrew D. ;
Graham, Cat ;
Wild, Sarah H. ;
Slack, Rachel ;
Pell, Jill P. ;
Newby, David E. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (03) :236-242
[5]   Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents - A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians [J].
Grines, Cindy L. ;
Bonow, Robert O. ;
Casey, Donald E., Jr. ;
Gardner, Timothy J. ;
Lockhart, Peter B. ;
Moliterno, David J. ;
O'Gara, Patrick ;
Whitlow, Patrick .
CIRCULATION, 2007, 115 (06) :813-818
[6]   Catastrophic outcomes of noncardiac surgery soon after coronary stenting [J].
Kaluza, GL ;
Joseph, J ;
Lee, JR ;
Raizner, ME ;
Raizner, AE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (05) :1288-1294
[7]   Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan [J].
Kimura T. ;
Morimoto T. ;
Furukawa Y. ;
Nakagawa Y. ;
Kadota K. ;
Iwabuchi M. ;
Shizuta S. ;
Shiomi H. ;
Tada T. ;
Tazaki J. ;
Kato Y. ;
Hayano M. ;
Abe M. ;
Tamura T. ;
Shirotani M. ;
Miki S. ;
Matsuda M. ;
Takahashi M. ;
Ishii K. ;
Tanaka M. ;
Aoyama T. ;
Doi O. ;
Hattori R. ;
Tatami R. ;
Suwa S. ;
Takizawa A. ;
Takatsu Y. ;
Takahashi M. ;
Kato H. ;
Takeda T. ;
Lee J.-D. ;
Nohara R. ;
Ogawa H. ;
Tei C. ;
Horie M. ;
Kambara H. ;
Fujiwara H. ;
Mitsudo K. ;
Nobuyoshi M. ;
Kita T. .
Cardiovascular Intervention and Therapeutics, 2011, 26 (3) :234-245
[8]  
Kimura T, 2010, CARDIOVASC INTERV TH, V25, P29, DOI 10.1007/s12928-009-0005-4
[9]   Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation [J].
Kimura, Takeshi ;
Morimoto, Takeshi ;
Nakagawa, Yoshihisa ;
Tamura, Toshihiro ;
Kadota, Kazushige ;
Yasumoto, Hitoshi ;
Nishikawa, Hideo ;
Hiasa, Yoshikazu ;
Muramatsu, Toshiya ;
Meguro, Taiichiro ;
Inoue, Naoto ;
Honda, Hidehiko ;
Hayashi, Yasuhiko ;
Miyazaki, Shunichi ;
Oshima, Shigeru ;
Honda, Takashi ;
Shiode, Nobuo ;
Namura, Masanobu ;
Sone, Takahito ;
Nobuyoshi, Masakiyo ;
Kita, Toru ;
Mitsudo, Kazuaki .
CIRCULATION, 2009, 119 (07) :987-U120
[10]   Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy [J].
McFadden, EP ;
Stabile, E ;
Regar, E ;
Cheneau, E ;
Ong, ATL ;
Kinnaird, T ;
Suddath, WO ;
Weissman, NJ ;
Torguson, R ;
Kent, KM ;
Pichard, AD ;
Satler, LF ;
Waksman, R ;
Serruys, PW .
LANCET, 2004, 364 (9444) :1519-1521